| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 3,099 | 3,394 | 2,728 | 565 | | Cost of Revenue | 2,169 | 1,988 | 1,824 | 2,247 | | | Gross Profit | 930 | 1,406 | 904 | (1,682) | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 834 | 638 | 551 | 2,042 | | Non Recurring | (49) | (3) | 274 | 21,834 | | Others | 751 | 885 | 1,100 | 1,544 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (606) | (114) | (1,021) | (27,102) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 42 | (12) | (47) | 50 | | Earnings Before Interest And Taxes | (614) | (159) | (1,158) | (26,924) | | Interest Expense |
-
|
-
|
-
| 219 | | Income Before Tax | (614) | (159) | (1,158) | (27,143) | | Income Tax Expense |
-
|
-
| (40) | 4 | | Minority Interest | 160 |
-
|
-
| 133 | | | | Net Income From Continuing Ops | (627) | (159) | (1,118) | (27,014) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (454) | (159) | (1,118) | (27,014) | | Preferred Stock And Other Adjustments | (73) | (189) | (93) | (127) | | | Net Income Applicable To Common Shares | ($527) | ($348) | ($1,211) | ($27,141) |
|
0.01% Nasdaq 
0.14 (3.59%) 
Income Statement
